ШИЗОФРЕНИЯ: краткое введение
Шрифт:
Classifying symptoms: T. J. Crow, «Molecular pathology of schizophrenia: more than one disease process?», British Medical Journal(1980), 280(6207): 66-8.
Intellectual functioning and symptoms: E. C. Johnstone and C. D. Frith, «Validation of three dimensions of schizophrenic symptoms in a large unselected sample of patients». Psychological Medicine(1996), 26(4): 669-79.
Genius and madness: N. C. Andreasen, «Creativity and mental illness: prevalence rates in writers and their first-degree relatives». The American Journal of Psychiatry(1987), 144(10): 1.288-92; A. M. Ludwig,
Superior abilities in the relatives of patients with schizophrenia: J. L. Karlsson, «Mental abilities of male relatives of psychotic patients», Acta Psychiatrica Scandinavica(2001), 104(6): 466-8.
Глава 4
Amphetamine psychosis: P. H. Connell, Amphetamine Psychosis(Maudsley Monographs, 1958); S. Tatetsu, «Metamphetamine psychosis», in Current Concepts of Amphetamine Abuse,ed. E. H. Elinwood (Rockville NIMH, 1972).
Experimental studies of amphetamine: J. D. Griffith, J. H. Cavanaugh, J. Held, et al., «Experimental psychosis induced by the administration of d-amphetamine», in Amphetamine and Related Compounds,ed. E. Costa and S. Garattini (Raven Press, 1970), pp. 897–904;
В. M. Angrist and S. Gershon, «The phenomenology of experimentally induced amphetamine psychosis: Preliminary observations». Biological Psychiatry(1970), 2: 95-107.
Amphetamine and dopamine: L. Kokkinidis and H. Anisman, «Amphetamine psychosis and schizophrenia — a dual model», Neuroscience and Biobehavioral Reviews(1981), 5 (4): 449-61.
Cannabis and schizophrenia: S. Andreasson, A. Engstrom, P. Allebeck, and U. Rydberg, «Cannabis and schizophrenia — a longitudinal study of Swedish conscripts». Lancet(1987), 2 (8574): 1483-6; W. Hall and L. Degenhardt, «Cannabis use and psychosis: a review of clinical and epidemiological evidence», Australian and New Zealand Journal of Psychiatry(2000), 34 (1): 26–34.
The cannabis receptor: M. Glass, «The role of cannabinoids in neurodegenerative diseases». Progress in Neuro-Psychopharmacology and Biological Psychiatry(2001), 25 (4): 743-65.
PCP and schizophrenia: D. C. Javitt and S. R. Zukin, «Recent advances in the phencyclidine model of schizophrenia», American Journal of Psychiatry(1991), 148 (10): 1301-8.
Discovery of antipsychotic drugs: J. Delay and P. Deniker, «Le traitement des psychoses par une m'ethode neurolyptique d'eriv'ee de l'hibernoth'erapie», in Congres de M'edicins Ali'enistes et Neurologistes de France,ed. P. Cossa (Maisson Editeurs Libraires de I’Acad'emie de M'edicine, Paris, 1952), pp. 497–502.
Efficacy of antipsychotic drugs: J. M. Davis and D. L. Gerver,
Dopamine and Parkinson's disease: 0. Hornykiewicz, «Dopamine in the basal ganglia. Its role and therapeutic implications (including the clinical use of L-DOPA)», British Medical Bulletin(1973), 29: 172-8.
The dopamine theory of schizophrenia: A. Carlsson and M. Lindquist, «Effect of chlorpromazine and haloperidol of formation of 3-methoxytyramine and normetanephrine in mouse brain», Acta Pharmacol. Toxicol.(1963): 140-4.
Dopamine blockade and the efficacy of antipsychotic drugs: P. Seeman et al., «Antipsychotic drug doses and neuroleptic/dopamine receptors». Nature(1976), 261: 717-9.
Atypical antipsychotics: J. Kane, G. Honigfeld, J. Singer, and H. Meltzer, «Clozapine for the treatment-resistant schizophrenic. A double-blind comparison with chlorpromazine». Archives of General Psychiatry(1988), 45: 789-96.
A revised dopamine theory of schizophrenia: S. Kapur and G. Remington, «Dopamine D(2) receptors and their role in atypical antipsychotic action: still necessary and may even be sufficient», Biological Psychiatry(2001), 50: 873-83.
Imaging dopamine receptors: M. Laruelle, «Imaging dopamine transmission in schizophrenia. A review and meta-analysis». Quarterly Journal of Nuclear Medicine(1998), 42: 211-21.
Глава 5
Neuropathology of schizophrenia: Paul J. Harrison, «The neuropathology of schizophrenia: A critical review of the data and their interpretation». Brain(1999), 122: 593-62.
Genetics of schizophrenia: 1.1. Gottesman, Scnizophrenia Genesis: The Origins of Madness(W. H. Freeman & Co, 1991).
Adoption studies: S. S. Kety et at., «Mental illness in the biological and adoptive families of adopted individuals who have become schizophrenic: a preliminary report based on psychiatric interviews», Proceedings of the Annual Meeting of the American Psychopathology Association(1975), 63: 147-65.
Genetic linkage studies: K. S. Kendler, «The feasibility of linkage studies in schizophrenia», in Biological Perspectives of Schizophrenia,ed. H. Helmchan and F. A. Henn (Wylie, 1987).
Susceptibility genes in schizophrenia: C. R. Cloninger, «The discovery of susceptibility genes for mental disorders». Proceedings of the National Academy of Sciences, USA(2002), 99: 13365-7.
Velo-cardio facial syndrome: К. C. Murphy and M. J. Owen, «Velocardio facial syndrome. A model for understanding the genetics and pathogenesis of schizophrenia», British Journal of Psychiatry(2001), 179: 397–402.